<DOC>
	<DOCNO>NCT00945061</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray type radiation kill tumor cell . It yet know whether single dose radiation therapy effective implant radiation therapy 5 day treat patient recurrent breast cancer . PURPOSE : This phase II trial study implant radiation therapy see well work compare radiation therapy surgery treat patient recurrent breast cancer .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Recurrent Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine breast recurrence rate follow repeat radiation breast Mammosite® brachytherapy intraoperative radiotherapy patient recurrent ipsilateral breast cancer . - To determine cosmetic outcome result partial breast re-irradiation use different technique , include physician- patient-rated scale . - To determine patient satisfaction partial breast re-irradiation pertain overall treatment experience , measure questionnaire . - To determine patient factor limit patient 's suitability receive partial breast re-irradiation deliver particular technique . - To evaluate tylectomy wound heal overall complication rate partial breast re-irradiation . - To determine ipsilateral breast tumor recurrence rate tumor bed recurrence rate . OUTLINE : Patients stratify accord modality best suit patient . Patients assign 1 2 group . All patient undergo excisional biopsy needle localization removal tumor . Patients margin &lt; 2 mm undergo re-excision biopsy cavity . - Group 1 : Patients undergo partial breast irradiation deliver single intra-operative radiation dose tumor bed . - Group 2 : Patients undergo partial breast irradiation deliver Mammosite® brachytherapy consist 10 fraction 5 day . Quality life assess baseline , 1 month completion radiotherapy , follow-up visit . After completion study treatment , patient follow 1 month , every 3 month 1 year , every 6 month 5 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm ductal carcinoma situ ( DCIS ) invasive carcinoma breast ( ductal , medullary , papillary , colloid [ mucinous ] , tubular ) meeting follow criterion : Lesion size ≤ 3 cm treat tylectomy whole breast irradiation ( without tumor bed boost ) Unifocal breast cancer recurrence Negative resection margin ≥ 2 mm margin invasive situ cancer negative reexcision Patients clinically radiographically negative axilla undergo axillary lymph node dissection unless prior axillary lymph node sampling ( i.e. , previous cancer DCIS ) No invasive lobular carcinoma , extensive lobular carcinoma situ , extensive DCIS ( ≥ 3 cm ) , nonepithelial breast malignancy lymphoma sarcoma No multicentric carcinoma ( tumor different quadrant breast tumor separate ≥ 4 cm ) No palpable radiographically suspicious contralateral axillary , ipsilateral , contralateral supraclavicular , infraclavicular , internal mammary lymph node unless histologically cytologically confirm negative No extensive intraductal component Harvard definition , i.e. , 25 % invasive tumor DCIS DCIS present adjacent breast tissue No distant metastatic disease No Paget 's disease nipple No skin involvement No known BRCA1/BRCA2 mutation Hormone receptor status specify PATIENT CHARACTERISTICS : Menopausal status specify No collagen vascular disorder , i.e. , systemic lupus erythematosus , scleroderma , dermatomyositis No psychiatric , neurologic , addictive disorder would preclude study participation No malignancy within past 5 year except nonmelanoma skin cancer Not pregnant nursing Negative pregnancy test PRIOR CONCURRENT THERAPY : See Disease Characteristics At least 5 year since prior radiotherapy No chemotherapy within 2 week completion radiotherapy Concurrent hormonal therapy allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ductal breast carcinoma situ</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>invasive ductal breast carcinoma</keyword>
	<keyword>medullary ductal breast carcinoma lymphocytic infiltrate</keyword>
	<keyword>mucinous ductal breast carcinoma</keyword>
	<keyword>papillary ductal breast carcinoma</keyword>
	<keyword>tubular ductal breast carcinoma</keyword>
	<keyword>male breast cancer</keyword>
</DOC>